Filing search / Centessa Pharmaceuticals plc / "Access" / Page 2

8-K

EX-3.1

u4skmpzvd

6 Oct 22

Other Events

5:06pm

S-3

3if1mt5o1td0t81

1 Jul 22

Shelf registration

4:06pm

DEFA14A

z6yquv5h897nh494j1

9 Jun 22

Additional proxy soliciting materials

9:06am

DEF 14A

1sueb50qvs mw6xcowc8

23 May 22

Definitive proxy

8:00am

10-K

9ddrx6ulm0b 38uiny

30 Mar 22

Annual report

12:00am

10-K

EX-10.35

14kb8g a9ipv

30 Mar 22

Annual report

12:00am

10-K

EX-10.34

w1a8ff j7vpoehr6

30 Mar 22

Annual report

12:00am

8-K

EX-99.1

5n5is8ipzeil

15 Nov 21

Centessa Pharmaceuticals Announces Third Quarter 2021 Financial Results and Business Updates

7:11am

8-K

EX-99.1

ejvu2qwx

1 Nov 21

Regulation FD Disclosure

7:38am

8-K

EX-99.2

sj65rjy26tn

1 Nov 21

Regulation FD Disclosure

7:38am

8-K

EX-99.1

yoi 067rd2fo352s

4 Oct 21

Centessa Pharmaceuticals Announces $300 Million Financing Agreement with Oberland Capital

8:07am

8-K

EX-99.1

w8wpum

9 Sep 21

Regulation FD Disclosure

7:34am